Back to results
US 12,708,661 B2Granted
Treatment of brain damage
AssigneeIpsen Biopharm Ltd.
InventorMikhail Kalinichev
Life of this patent
Estimating the term…
Abstract
The present invention provides a clostridial neurotoxin for use in a method of treating a brain disorder in a patient by promoting a neuroimmune response.
Claims20
A method for increasing microglial cell density in a patient in need thereof, the method comprising administering a clostridial neurotoxin to the patient, wherein the clostridial neurotoxin comprises botulinum neurotoxin A (BoNT/A).
Dependencies are inferred from the claim text.